MedTrace Logo

ESBL in Patients Returning to Sweden With Traveller's Diarrhoea

NCT03866291 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 305

Last updated 2019-07-02

No results posted yet for this study

Summary

Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas.

This study investigates to what extent travellers returning to Sweden with traveller's diarrhoea carry ESBL in their stool. The isolates are examined further according to species, phenotype, antibiogram and whole genome sequencing.

Conditions

  • Antibiotic Resistant Infection
  • Antibiotic Resistant Strain
  • Traveler's Diarrhea

Interventions

OTHER

No intervention, observational

See above

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Oskar Ljungquist · Lunds Universitet

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-06-20
Completion
2019-06-20

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866291 on ClinicalTrials.gov